{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:54:44Z","timestamp":1787961284495,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan","award":["AP09260233"],"award-info":[{"award-number":["AP09260233"]}]},{"name":"Nazarbayev University CRP","award":["091019CRP2111"],"award-info":[{"award-number":["091019CRP2111"]}]},{"name":"Ligue Contre le Cancer Comit\u00e9 du Val de Marne"},{"DOI":"10.13039\/501100004097","name":"Fondation ARC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["5R01CA213223"],"award-info":[{"award-number":["5R01CA213223"]}]},{"name":"La Ligue Nationale Fran\u00e7aise Contre le Cancer","award":["Equipe LNCC 2016"],"award-info":[{"award-number":["Equipe LNCC 2016"]}]},{"DOI":"10.13039\/501100016036","name":"Electricit\u00e9 de France","doi-asserted-by":"publisher","award":["RB 2021-05"],"award-info":[{"award-number":["RB 2021-05"]}],"id":[{"id":"10.13039\/501100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE12-0034-01"],"award-info":[{"award-number":["ANR-22-CE12-0034-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anti-neoplastic effect of DNA cross-linking agents such as cisplatin, mitomycin C, and psoralen is attributed to their ability to induce DNA interstrand cross-links (ICLs), which block replication, transcription, and linear repair pathways by preventing DNA strand separation and trigger apoptosis. It is generally agreed that the Fanconi anemia (FA) pathway orchestrates the removal of ICLs by the combined actions of various DNA repair pathways. Recently, attention has been focused on the ability of the NEIL3-initiated base excision repair pathway to resolve psoralen- and abasic site-induced ICLs in an FA-independent manner. Intriguingly, overexpression of NEIL3 is associated with chemo-resistance and poor prognosis in many solid tumors. Here, using loss- and gain-of-function approaches, we demonstrate that NEIL3 confers resistance to cisplatin and participates in the removal of cisplatin\u2013DNA adducts. Proteomic studies reveal that the NEIL3 protein interacts with the 26S proteasome in a cisplatin-dependent manner. NEIL3 mediates proteasomal degradation of WRNIP1, a protein involved in the early step of ICL repair. We propose that NEIL3 participates in the repair of ICL-stalled replication fork by recruitment of the proteasome to ensure a timely transition from lesion recognition to repair via the degradation of early-step vanguard proteins.<\/jats:p>","DOI":"10.1038\/s41598-023-32186-3","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T10:03:56Z","timestamp":1680170636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["NEIL3-mediated proteasomal degradation facilitates the repair of cisplatin-induced DNA damage in human cells"],"prefix":"10.1038","volume":"13","author":[{"given":"Umit","family":"Aliyaskarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeldar","family":"Baiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Couve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei F.","family":"Kisselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Saparbaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Groisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,30]]},"reference":[{"key":"32186_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"S Rottenberg","year":"2021","unstructured":"Rottenberg, S., Disler, C. & Perego, P. The rediscovery of platinum-based cancer therapy. Nat. Rev. Cancer 21, 37\u201350 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"32186_CR2","doi-asserted-by":"publisher","first-page":"e478s","DOI":"10.6061\/clinics\/2018\/e478s","volume":"73","author":"CRR Rocha","year":"2018","unstructured":"Rocha, C. R. R. et al. DNA repair pathways and cisplatin resistance: an intimate relationship. Clinics 73, e478s (2018).","journal-title":"Clinics"},{"key":"32186_CR3","first-page":"9","volume":"38","author":"S Hashimoto","year":"2016","unstructured":"Hashimoto, S., Anai, H. & Hanada, K. Mechanisms of interstrand DNA crosslink repair and human disorders. Genes Environ. Off. J. Jpn. Environ. Mutagen. Soc. 38, 9 (2016).","journal-title":"Genes Environ. Off. J. Jpn. Environ. Mutagen. Soc."},{"key":"32186_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.dnarep.2016.05.004","volume":"44","author":"U Roy","year":"2016","unstructured":"Roy, U. & Sch\u00e4rer, O. D. Involvement of translesion synthesis DNA polymerases in DNA interstrand crosslink repair. DNA Repair 44, 33\u201341 (2016).","journal-title":"DNA Repair"},{"key":"32186_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrc3088","volume":"11","author":"AJ Deans","year":"2011","unstructured":"Deans, A. J. & West, S. C. DNA interstrand crosslink repair and cancer. Nat. Rev. Cancer 11, 467\u2013480 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"32186_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.dnarep.2014.03.018","volume":"19","author":"J Zhang","year":"2014","unstructured":"Zhang, J. & Walter, J. C. Mechanism and regulation of incisions during DNA interstrand cross-link repair. DNA Repair 19, 135\u2013142 (2014).","journal-title":"DNA Repair"},{"key":"32186_CR7","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1093\/nar\/gks670","volume":"40","author":"M Enoiu","year":"2012","unstructured":"Enoiu, M., Jiricny, J. & Sch\u00e4rer, O. D. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis. Nucleic Acids Res. 40, 8953\u20138964 (2012).","journal-title":"Nucleic Acids Res."},{"key":"32186_CR8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1101\/gad.15699211","volume":"25","author":"AT Wang","year":"2011","unstructured":"Wang, A. T. et al. Human SNM1A and XPF\u2013ERCC1 collaborate to initiate DNA interstrand cross-link repair. Genes Dev. 25, 1859\u20131870 (2011).","journal-title":"Genes Dev."},{"key":"32186_CR9","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1128\/MCB.22.7.2388-2397.2002","volume":"22","author":"N Zhang","year":"2002","unstructured":"Zhang, N., Lu, X., Zhang, X., Peterson, C. A. & Legerski, R. J. hMutS\u03b2 is required for the recognition and uncoupling of psoralen interstrand cross-links in vitro. Mol. Cell. Biol. 22, 2388\u20132397 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"32186_CR10","doi-asserted-by":"publisher","first-page":"a012583","DOI":"10.1101\/cshperspect.a012583","volume":"5","author":"HE Krokan","year":"2013","unstructured":"Krokan, H. E. & Bj\u00f8r\u00e5s, M. Base excision repair. Cold Spring Harb. Perspect. Biol. 5, a012583 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"32186_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mrfmmm.2012.12.003","volume":"743\u2013744","author":"M Liu","year":"2013","unstructured":"Liu, M., Doubli\u00e9, S. & Wallace, S. S. Neil3, the final frontier for the DNA glycosylases that recognize oxidative damage. Mutat. Res. 743\u2013744, 4\u201311 (2013).","journal-title":"Mutat. Res."},{"key":"32186_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41586-019-1002-0","volume":"567","author":"RA Wu","year":"2019","unstructured":"Wu, R. A. et al. TRAIP is a master regulator of DNA interstrand crosslink repair. Nature 567, 267\u2013272 (2019).","journal-title":"Nature"},{"key":"32186_CR13","doi-asserted-by":"publisher","first-page":"15566","DOI":"10.1074\/jbc.RA120.015541","volume":"295","author":"AA Rodriguez","year":"2020","unstructured":"Rodriguez, A. A. et al. An autoinhibitory role for the GRF zinc finger domain of DNA glycosylase NEIL3. J. Biol. Chem. 295, 15566\u201315575 (2020).","journal-title":"J. Biol. Chem."},{"key":"32186_CR14","doi-asserted-by":"publisher","first-page":"14222","DOI":"10.1074\/jbc.RA120.014228","volume":"295","author":"A Ha","year":"2020","unstructured":"Ha, A., Lin, Y. & Yan, S. A non-canonical role for the DNA glycosylase NEIL3 in suppressing APE1 endonuclease-mediated ssDNA damage. J. Biol. Chem. 295, 14222\u201314235 (2020).","journal-title":"J. Biol. Chem."},{"key":"32186_CR15","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/nar\/gkaa038","volume":"48","author":"N Li","year":"2020","unstructured":"Li, N. et al. Cooperation of the NEIL3 and Fanconi anemia\/BRCA pathways in interstrand crosslink repair. Nucleic Acids Res. 48, 3014\u20133028 (2020).","journal-title":"Nucleic Acids Res."},{"key":"32186_CR16","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.1074\/jbc.M900746200","volume":"284","author":"S Couv\u00e9","year":"2009","unstructured":"Couv\u00e9, S., Mac\u00e9-Aim\u00e9, G., Rosselli, F. & Saparbaev, M. K. The human oxidative DNA glycosylase NEIL1 excises psoralen-induced interstrand DNA cross-links in a three-stranded DNA structure. J. Biol. Chem. 284, 11963\u201311970 (2009).","journal-title":"J. Biol. Chem."},{"key":"32186_CR17","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1093\/nar\/gkm592","volume":"35","author":"S Couv\u00e9-Privat","year":"2007","unstructured":"Couv\u00e9-Privat, S., Mac\u00e9, G., Rosselli, F. & Saparbaev, M. K. Psoralen-induced DNA adducts are substrates for the base excision repair pathway in human cells. Nucleic Acids Res. 35, 5672\u20135682 (2007).","journal-title":"Nucleic Acids Res."},{"key":"32186_CR18","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1038\/s41598-017-17693-4","volume":"7","author":"PR Martin","year":"2017","unstructured":"Martin, P. R. et al. The human DNA glycosylases NEIL1 and NEIL3 excise Psoralen-induced DNA-DNA cross-links in a four-stranded DNA structure. Sci. Rep. 7, 17438 (2017).","journal-title":"Sci. Rep."},{"key":"32186_CR19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.cell.2016.09.008","volume":"167","author":"DR Semlow","year":"2016","unstructured":"Semlow, D. R., Zhang, J., Budzowska, M., Drohat, A. C. & Walter, J. C. Replication-dependent unhooking of DNA interstrand cross-links by the NEIL3 glycosylase. Cell 167, 498-511.e14 (2016).","journal-title":"Cell"},{"key":"32186_CR20","doi-asserted-by":"publisher","first-page":"112942","DOI":"10.18632\/oncotarget.22896","volume":"8","author":"AW Klattenhoff","year":"2017","unstructured":"Klattenhoff, A. W. et al. Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells. Oncotarget 8, 112942\u2013112958 (2017).","journal-title":"Oncotarget"},{"key":"32186_CR21","doi-asserted-by":"publisher","first-page":"101042832091840","DOI":"10.1177\/1010428320918404","volume":"42","author":"OT Tran","year":"2020","unstructured":"Tran, O. T., Tadesse, S., Chu, C. & Kidane, D. Overexpression of NEIL3 associated with altered genome and poor survival in selected types of human cancer. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 42, 1010428320918404 (2020).","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"32186_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.dnarep.2019.04.008","volume":"78","author":"WH Chang","year":"2019","unstructured":"Chang, W. H. & Lai, A. G. Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia. DNA Repair 78, 142\u2013153 (2019).","journal-title":"DNA Repair"},{"key":"32186_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.onc.1210700","volume":"27","author":"A Kauffmann","year":"2008","unstructured":"Kauffmann, A. et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 27, 565\u2013573 (2008).","journal-title":"Oncogene"},{"key":"32186_CR24","doi-asserted-by":"publisher","first-page":"e1546392","DOI":"10.1155\/2016\/1546392","volume":"2016","author":"K Shinmura","year":"2016","unstructured":"Shinmura, K. et al. Abnormal expressions of DNA glycosylase genes NEIL1, NEIL2, and NEIL3 are associated with somatic mutation loads in human cancer. Oxid. Med. Cell. Longev. 2016, e1546392 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"32186_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.bbamcr.2012.12.024","volume":"1833","author":"V Rolseth","year":"2013","unstructured":"Rolseth, V. et al. Loss of Neil3, the major DNA glycosylase activity for removal of hydantoins in single stranded DNA, reduces cellular proliferation and sensitizes cells to genotoxic stress. Biochim. Biophys. Acta BBA Mol. Cell Res. 1833, 1157\u20131164 (2013).","journal-title":"Biophys. Acta BBA Mol. Cell Res."},{"key":"32186_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425\u2013479 (1998).","journal-title":"Annu. Rev. Biochem."},{"key":"32186_CR27","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/cancers13092235","volume":"13","author":"JJ Morgan","year":"2021","unstructured":"Morgan, J. J. & Crawford, L. J. The ubiquitin proteasome system in genome stability and cancer. Cancers 13, 2235 (2021).","journal-title":"Cancers"},{"key":"32186_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","volume":"78","author":"D Finley","year":"2009","unstructured":"Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477\u2013513 (2009).","journal-title":"Annu. Rev. Biochem."},{"key":"32186_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.molcel.2013.01.017","volume":"49","author":"SP Jackson","year":"2013","unstructured":"Jackson, S. P. & Durocher, D. Regulation of DNA Damage Responses by Ubiquitin and SUMO. Mol. Cell 49, 795\u2013807 (2013).","journal-title":"Mol. Cell"},{"key":"32186_CR30","doi-asserted-by":"publisher","first-page":"103128","DOI":"10.1016\/j.dnarep.2021.103128","volume":"103","author":"AK Chauhan","year":"2021","unstructured":"Chauhan, A. K., Sun, Y., Zhu, Q. & Wani, A. A. Timely upstream events regulating nucleotide excision repair by ubiquitin-proteasome system: ubiquitin guides the way. DNA Repair 103, 103128 (2021).","journal-title":"DNA Repair"},{"key":"32186_CR31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.molcel.2004.11.033","volume":"16","author":"NJ Krogan","year":"2004","unstructured":"Krogan, N. J. et al. Proteasome involvement in the repair of DNA double-strand breaks. Mol. Cell 16, 1027\u20131034 (2004).","journal-title":"Mol. Cell"},{"key":"32186_CR32","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1158\/0008-5472.CAN-07-1015","volume":"67","author":"C Jacquemont","year":"2007","unstructured":"Jacquemont, C. & Taniguchi, T. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Res. 67, 7395\u20137405 (2007).","journal-title":"Cancer Res."},{"key":"32186_CR33","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1101\/gad.378206","volume":"20","author":"R Groisman","year":"2006","unstructured":"Groisman, R. et al. CSA-dependent degradation of CSB by the ubiquitin\u2013proteasome pathway establishes a link between complementation factors of the Cockayne syndrome. Genes Dev. 20, 1429\u20131434 (2006).","journal-title":"Genes Dev."},{"key":"32186_CR34","doi-asserted-by":"publisher","first-page":"107850","DOI":"10.1016\/j.celrep.2020.107850","volume":"32","author":"A Socha","year":"2020","unstructured":"Socha, A. et al. WRNIP1 is recruited to DNA interstrand crosslinks and promotes repair. Cell Rep. 32, 107850 (2020).","journal-title":"Cell Rep."},{"key":"32186_CR35","doi-asserted-by":"crossref","unstructured":"Nakatani, Y. & Ogryzko, V. Immunoaffinity Purification of Mammalian Protein Complexes. in Methods in Enzymology vol. 370 430\u2013444 (Elsevier, 2003).","DOI":"10.1016\/S0076-6879(03)70037-8"},{"key":"32186_CR36","doi-asserted-by":"publisher","first-page":"e45566","DOI":"10.15252\/embr.201745566","volume":"19","author":"IK Mandemaker","year":"2018","unstructured":"Mandemaker, I. K. et al. DNA damage-induced replication stress results in PA200-proteasome-mediated degradation of acetylated histones. EMBO Rep. 19, e45566 (2018).","journal-title":"EMBO Rep."},{"key":"32186_CR37","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cell.2013.04.032","volume":"153","author":"M-X Qian","year":"2013","unstructured":"Qian, M.-X. et al. Acetylation-mediated proteasomal degradation of core histones during DNA repair and spermatogenesis. Cell 153, 1012\u20131024 (2013).","journal-title":"Cell"},{"key":"32186_CR38","doi-asserted-by":"publisher","first-page":"31608","DOI":"10.1074\/jbc.M801082200","volume":"283","author":"W Shi","year":"2008","unstructured":"Shi, W. et al. Disassembly of MDC1 foci is controlled by ubiquitin-proteasome-dependent degradation. J. Biol. Chem. 283, 31608\u201331616 (2008).","journal-title":"J. Biol. Chem."},{"key":"32186_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.molcel.2017.04.022","volume":"66","author":"S Inano","year":"2017","unstructured":"Inano, S. et al. RFWD3-mediated ubiquitination promotes timely removal of both RPA and RAD51 from DNA damage sites to facilitate homologous recombination. Mol. Cell 66, 622-634.e8 (2017).","journal-title":"Mol. Cell"},{"key":"32186_CR40","doi-asserted-by":"publisher","first-page":"20705","DOI":"10.1073\/pnas.0907052106","volume":"106","author":"M Harreman","year":"2009","unstructured":"Harreman, M. et al. Distinct ubiquitin ligases act sequentially for RNA polymerase II polyubiquitylation. Proc. Natl. Acad. Sci. 106, 20705\u201320710 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"32186_CR41","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1038\/s41467-020-18705-0","volume":"11","author":"C Ribeiro-Silva","year":"2020","unstructured":"Ribeiro-Silva, C. et al. Ubiquitin and TFIIH-stimulated DDB2 dissociation drives DNA damage handover in nucleotide excision repair. Nat. Commun. 11, 4868 (2020).","journal-title":"Nat. Commun."},{"key":"32186_CR42","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41580-019-0169-4","volume":"20","author":"H Lans","year":"2019","unstructured":"Lans, H., Hoeijmakers, J. H. J., Vermeulen, W. & Marteijn, J. A. The DNA damage response to transcription stress. Nat. Rev. Mol. Cell Biol. 20, 766\u2013784 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"32186_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","volume":"16","author":"AC Lai","year":"2017","unstructured":"Lai, A. C. & Crews, C. M. Induced protein degradation: An emerging drug discovery paradigm. Nat. Rev. Drug Discov. 16, 101\u2013114 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"32186_CR44","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3390\/biom4041026","volume":"4","author":"TS McCann","year":"2014","unstructured":"McCann, T. S. & Tansey, W. P. Functions of the proteasome on chromatin. Biomolecules 4, 1026\u20131044 (2014).","journal-title":"Biomolecules"},{"key":"32186_CR45","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/0008-5472.CAN-12-3000","volume":"73","author":"J Michels","year":"2013","unstructured":"Michels, J. et al. Cisplatin resistance associated with PARP hyperactivation. Cancer Res. 73, 2271\u20132280 (2013).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32186-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T10:18:20Z","timestamp":1680171500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32186-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32186"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32186-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,30]]},"assertion":[{"value":"11 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AFK is the founder and chief scientific officer of InhiProt LLC. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5174"}}